Concepedia

Barry R. Dillon

BR

Statistics

Publications

9

Citations

642

H-Index

9

Active since

2011

Affiliations

AstraZeneca (United Kingdom)(Current)

Pfizer (United Kingdom)

Pfizer (United States)

University of Edinburgh

Merck & Co., Inc., Rahway, NJ, USA (United States)

Barry R. Dillon is an author at AstraZeneca (United Kingdom) specializing in natural sciences, chemistry, and reaction engineering.

Publications per year

2011–2019

9

Publications

9

Recent Advances of Manganese Catalysis for Organic Synthesis

Jonathan R. Carney, Barry R. Dillon, Stephen P. Thomas · European Journal of Organic Chemistry · 2016 · 281 citations

, , +17

Manganese‐Catalyzed Hydrofunctionalization of Alkenes

Jonathan R. Carney, Barry R. Dillon, Leonie Campbell et al. · Angewandte Chemie International Edition · 2018 · 126 citations · Full text

, , +16

The PMI Predictor app to enable green-by-design chemical synthesis

Alina Borovika, Jacob Albrecht, Jun Li et al. · Nature Sustainability · 2019 · 59 citations

, , +9

Sustainable chromatography (an oxymoron?)

Emily A. Peterson, Barry R. Dillon, Izzat T. Raheem et al. · Green Chemistry · 2014 · 56 citations

, , +17

Inhalation by Design: Novel Tertiary Amine Muscarinic M<sub>3</sub>Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary Disease

Paul A. Glossop, Christine Watson, David Price et al. · Journal of Medicinal Chemistry · 2011 · 33 citations · Full text

, , +17

1–5 of 9